論文

2012年12月

Protection by a recombinant Mycobacterium bovis Bacillus Calmette-Guérin vaccine expressing Shiga toxin 2 B subunit against Shiga toxin-producing Escherichia coli in mice

Clinical and Vaccine Immunology
  • Jun Fujii
  • ,
  • Mariko Naito
  • ,
  • Takashi Yutsudo
  • ,
  • Sohkichi Matsumoto
  • ,
  • Daniel P. Heatherly
  • ,
  • Takeshi Yamada
  • ,
  • Hideyuki Kobayashi
  • ,
  • Shin-Ichi Yoshida
  • ,
  • Tom Obrig

19
12
開始ページ
1932
終了ページ
1937
記述言語
英語
掲載種別
研究論文(学術雑誌)
DOI
10.1128/CVI.00473-12

We have developed a novel vaccine against Shiga toxin (Stx)-producing Escherichia coli (STEC) infection using a recombinant Mycobacterium bovis BCG (rBCG) system. Two intraperitoneal vaccinations with rBCG expressing the Stx2 B subunit (Stx2B) resulted in an increase of protective serum IgG and mucosal IgA responses to Stx2B in BALB/c mice. When orally challenged with 103 CFU of STEC strain B2F1 (O91: H21), the immunized mice survived statistically significantly longer than the nonvaccinated mice. We suggest that intraperitoneal immunization with rBCG expressing Stx2B would be a potential vaccine strategy for STEC. Copyright © 2012, American Society for Microbiology. All Rights Reserved.

リンク情報
DOI
https://doi.org/10.1128/CVI.00473-12
PubMed
https://www.ncbi.nlm.nih.gov/pubmed/23035176
ID情報
  • DOI : 10.1128/CVI.00473-12
  • ISSN : 1556-6811
  • ISSN : 1556-679X
  • PubMed ID : 23035176
  • SCOPUS ID : 84870419899

エクスポート
BibTeX RIS